The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
Open accessAbstract
SUMMARY Squamous cell carcinomas (SCCs) represent the most frequent human solid tumors and a major cause of cancer mortality. These highly heterogeneous tumors arise from closely interconnected epithelial cell populations with intrinsic self-renewal potential inversely related to the stratified differentiation program. SCCs can also originate from simple or pseudo-stratified epithelia through activation of quiescent cells and/or a switch in cell fate determination. Here, we focus on specific determinants implicated in the development of SCCs by recent large-scale genomic, genetic and epigenetic studies and complementary functional analysis. This evidence indicates that SCCs from various body sites, while clinically treated as separate entities, have common determinants, pointing to a unified perspective of the disease and potential new avenues for prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cai, L., Ye, Y., Jiang, Q., Chen, Y., Lyu, X., Li, J., Wang, S., Liu, T., Cai, H., Yao, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms8353 · Cited by 213
RetractedCerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Comprehensive genomic characterization of head and neck squamous cell carcinomas
The Cancer Genome Atlas Network (2015) · Nature · doi:10.1038/nature14129 · Cited by 3,877
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2982 · Cited by 2,524
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Herbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
The epidemiology of UV induced skin cancer
Armstrong, B. K., & Kricker, A. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00198-1 · Cited by 1,811
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Agrawal, N., Frederick, M. J., Pickering, C. R., Bettegowda, C., Chang, K., Li, R. J., Fakhry, C., Xie, T.-X., Zhang, J., Wang, J., et al. (2011) · Science · doi:10.1126/science.1206923 · Cited by 1,697
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
Hoadley, K. A., Yau, C., Wolf, D. M., Cherniack, A. D., Tamborero, D., Ng, S., Leiserson, M. D. M., Niu, B., McLellan, M. D., Uzunangelov, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.049 · Cited by 1,499
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
Rustgi, A. K., & El-Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,243
Self-citationHES and HERP families: Multiple effectors of the notch signaling pathway
Iso, T., Kedes, L., & Hamamori, Y. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10208 · Cited by 1,238
Review: Ultraviolet radiation and skin cancer
Narayanan, D. L., Saladi, R. N., & Fox, J. L. (2010) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04474.x · Cited by 1,184
Characterizing the cancer genome in lung adenocarcinoma
Weir, B. A., Woo, M. S., Getz, G., Perner, S., Ding, L., Beroukhim, R., Lin, W. M., Province, M. A., Kraja, A., Johnson, L. A., et al. (2007) · Nature · doi:10.1038/nature06358 · Cited by 1,105
Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Identification of genomic alterations in oesophageal squamous cell cancer
Song, Y., Li, L., Ou, Y., Gao, Z., Li, E., Li, X., Zhang, W., Wang, J., Xu, L., Zhou, Y., et al. (2014) · Nature · doi:10.1038/nature13176 · Cited by 1,083
Molecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Su, F., Viros, A., Milagre, C., Trunzer, K., Bollag, G., Spleiss, O., Reis-Filho, J. S., Kong, X., Koya, R. C., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105358 · Cited by 1,038
A Big Bang model of human colorectal tumor growth
Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., Marjoram, P., Siegmund, K., Press, M. F., Shibata, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3214 · Cited by 1,015
Asymmetric cell divisions promote stratification and differentiation of mammalian skin
Lechler, T., & Fuchs, E. (2005) · Nature · doi:10.1038/nature03922 · Cited by 998
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Bass, A. J., Watanabe, H., Mermel, C. H., Yu, S., Perner, S., Verhaak, R. G., Kim, S. Y., Wardwell, L., Tamayo, P., Gat-Viks, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.465 · Cited by 942
Self-citationHuman papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
Landscape of genomic alterations in cervical carcinomas
Ojesina, A. I., Lichtenstein, L., Freeman, S. S., Pedamallu, C. S., Imaz-Rosshandler, I., Pugh, T. J., Cherniack, A. D., Ambrogio, L., Cibulskis, K., Bertelsen, B., et al. (2014) · Nature · doi:10.1038/nature12881 · Cited by 867
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 782
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
Jeanes, A., Gottardi, C. J., & Yap, A. S. (2008) · Oncogene · doi:10.1038/onc.2008.343 · Cited by 772
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Genetic landscape of esophageal squamous cell carcinoma
Gao, Y.-B., Chen, Z.-L., Li, J.-G., Hu, X.-D., Shi, X.-J., Sun, Z.-M., Zhang, F., Zhao, Z.-R., Li, Z.-T., Liu, Z.-Y., et al. (2014) · Nature Genetics · doi:10.1038/ng.3076 · Cited by 694
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression
Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., Butterfoss, D., Xiang, D., Zanation, A., Yin, X., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00112-6 · Cited by 678
Seiwert, T. Y., Zuo, Z., Keck, M. K., Khattri, A., Pedamallu, C. S., Stricker, T., Brown, C., Pugh, T. J., Stojanov, P., Cho, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3310 · Cited by 657
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Le Mercier, M., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. (2014) · Nature · doi:10.1038/nature13305 · Cited by 656
Stem cells and the impact of ROS signaling
Bigarella, C. L., Liang, R., & Ghaffari, S. (2014) · Development · doi:10.1242/dev.107086 · Cited by 632
Genomic and molecular characterization of esophageal squamous cell carcinoma
Lin, D.-C., Hao, J.-J., Nagata, Y., Xu, L., Shang, L., Meng, X., Sato, Y., Okuno, Y., Varela, A. M., Ding, L.-W., et al. (2014) · Nature Genetics · doi:10.1038/ng.2935 · Cited by 626
Mutational landscape of aggressive cutaneous squamous cell carcinoma
Pickering, C. R., Zhou, J. H., Lee, J. J., Drummond, J. A., Peng, S. A., Saade, R. E., Tsai, K. Y., Curry, J. L., Tetzlaff, M. T., Lai, S. Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1768 · Cited by 612
Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells
Ezhkova, E., Pasolli, H. A., Parker, J. S., Stokes, N., Su, I.-H., Hannon, G., Tarakhovsky, A., & Fuchs, E. (2009) · Cell · doi:10.1016/j.cell.2008.12.043 · Cited by 604
IntOGen-mutations identifies cancer drivers across tumor types
Gonzalez-Perez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M. P., Jene-Sanz, A., Santos, A., & Lopez-Bigas, N. (2013) · Nature Methods · doi:10.1038/nmeth.2642 · Cited by 586
Asymmetric cell division: recent developments and their implications for tumour biology
Knoblich, J. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3010 · Cited by 578
Pickering, C. R., Zhang, J., Yoo, S. Y., Bengtsson, L., Moorthy, S., Neskey, D. M., Zhao, M., Ortega Alves, M. V., Chang, K., Drummond, J., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0537 · Cited by 559
Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia
Egawa, N., Egawa, K., Griffin, H., & Doorbar, J. (2015) · Viruses · doi:10.3390/v7072802 · Cited by 553
Que, J., Okubo, T., Goldenring, J. R., Nam, K.-T., Kurotani, R., Morrisey, E. E., Taranova, O., Pevny, L. H., & Hogan, B. L. M. (2007) · Development · doi:10.1242/dev.003855 · Cited by 518
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Genotoxicity of tobacco smoke and tobacco smoke condensate: a review
DeMarini, D. M. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.02.001 · Cited by 496
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Oshimori, N., Oristian, D., & Fuchs, E. (2015) · Cell · doi:10.1016/j.cell.2015.01.043 · Cited by 471
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma
Wang, N. J., Sanborn, Z., Arnett, K. L., Bayston, L. J., Liao, W., Proby, C. M., Leigh, I. M., Collisson, E. A., Gordon, P. B., Jakkula, L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114669108 · Cited by 462
Soria, J.-C., Felip, E., Cobo, M., Lu, S., Syrigos, K., Lee, K. H., Göker, E., Georgoulias, V., Li, W., Isla, D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00006-6 · Cited by 433
Tomasetti, C., Vogelstein, B., & Parmigiani, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221068110 · Cited by 414
Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes
Tubio, J. M. C., Li, Y., Ju, Y. S., Martincorena, I., Cooke, S. L., Tojo, M., Gundem, G., Pipinikas, C. P., Zamora, J., Raine, K., et al. (2014) · Science · doi:10.1126/science.1251343 · Cited by 412
Machiels, J.-P. H., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Vermorken, J. B., Clement, P. M., Gauler, T., Cupissol, D., Grau, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70124-5 · Cited by 394
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression
Xu, C., Fillmore, C. M., Koyama, S., Wu, H., Zhao, Y., Chen, Z., Herter-Sprie, G. S., Akbay, E. A., Tchaicha, J. H., Altabef, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.033 · Cited by 391
Self-citationGenomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors
Dienstmann, R., Rodon, J., Prat, A., Perez-Garcia, J., Adamo, B., Felip, E., Cortes, J., Iafrate, A. J., Nuciforo, P., & Tabernero, J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt419 · Cited by 365
NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis
South, A. P., Purdie, K. J., Watt, S. A., Haldenby, S., den Breems, N. Y., Dimon, M., Arron, S. T., Kluk, M. J., Aster, J. C., McHugh, A., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.154 · Cited by 357
Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
Cox, A. D., Der, C. J., & Philips, M. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3214 · Cited by 351
Zhang, L., Zhou, Y., Cheng, C., Cui, H., Cheng, L., Kong, P., Wang, J., Li, Y., Chen, W., Song, B., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.017 · Cited by 329
Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M., & Dotto, G. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5451 · Cited by 328
Self-citationElkabets, M., Pazarentzos, E., Juric, D., Sheng, Q., Pelossof, R. A., Brook, S., Benzaken, A. O., Rodon, J., Morse, N., Yan, J. J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.010 · Cited by 325 · cited 1×
“These features make them particularly difficult to target with monotherapeutic approaches (Elkabets et al., 2015).”
Pan, Y., Lin, M.-H., Tian, X., Cheng, H.-T., Gridley, T., Shen, J., & Kopan, R. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.09.014 · Cited by 325
Wang, F., Marshall, C. B., & Ikura, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1254-4 · Cited by 309
Lefort, K., Mandinova, A., Ostano, P., Kolev, V., Calpini, V., Kolfschoten, I., Devgan, V., Lieb, J., Raffoul, W., Hohl, D., et al. (2007) · Genes & Development · doi:10.1101/gad.1484707 · Cited by 305
Self-citationCritical role of p63 in the development of a normal esophageal and tracheobronchial epithelium
Daniely, Y., Liao, G., Dixon, D., Linnoila, R. I., Lori, A., Randell, S. H., Oren, M., & Jetten, A. M. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00226.2003 · Cited by 299
Justilien, V., Walsh, M. P., Ali, S. A., Thompson, E. A., Murray, N. R., & Fields, A. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.008 · Cited by 293
Opposing roles for calcineurin and ATF3 in squamous skin cancer
Wu, X., Nguyen, B.-C., Dziunycz, P., Chang, S., Brooks, Y., Lefort, K., Hofbauer, G. F. L., & Dotto, G. P. (2010) · Nature · doi:10.1038/nature08996 · Cited by 292
Self-citationRegulation and Role of EZH2 in Cancer
Yamaguchi, H., & Hung, M.-C. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.3.209 · Cited by 287
Paul, M. K., Bisht, B., Darmawan, D. O., Chiou, R., Ha, V. L., Wallace, W. D., Chon, A. T., Hegab, A. E., Grogan, T., Elashoff, D. A., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.05.009 · Cited by 286
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Brand, T. M., Iida, M., & Wheeler, D. L. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.9.15050 · Cited by 273
SOX2 and cancer: current research and its implications in the clinic
Weina, K., & Utikal, J. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-19 · Cited by 269
UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression
Bachelor, M. A., & Bowden, G. T. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.017 · Cited by 268
Epidermal Notch1 Loss Promotes Skin Tumorigenesis by Impacting the Stromal Microenvironment
Demehri, S., Turkoz, A., & Kopan, R. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.016 · Cited by 265
WU, Y., ZHANG, L., ZHANG, L., WANG, Y., LI, H., REN, X., WEI, F., YU, W., LIU, T., WANG, X., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2976 · Cited by 262
Chung, C. H., Parker, J. S., Ely, K., Carter, J., Yi, Y., Murphy, B. A., Ang, K. K., El-Naggar, A. K., Zanation, A. M., Cmelak, A. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1213 · Cited by 249
Notch tumor suppressor function
Dotto, G. P. (2008) · Oncogene · doi:10.1038/onc.2008.225 · Cited by 244
Self-citationSomatic retrotransposition in human cancer revealed by whole-genome and exome sequencing
Helman, E., Lawrence, M. S., Stewart, C., Sougnez, C., Getz, G., & Meyerson, M. (2014) · Genome Research · doi:10.1101/gr.163659.113 · Cited by 240
Skin-Derived TSLP Triggers Progression from Epidermal-Barrier Defects to Asthma
Demehri, S., Morimoto, M., Holtzman, M. J., & Kopan, R. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000067 · Cited by 226
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation
Procopio, M.-G., Laszlo, C., Al Labban, D., Kim, D. E., Bordignon, P., Jo, S.-H., Goruppi, S., Menietti, E., Ostano, P., Ala, U., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3228 · Cited by 223
Self-citationLechner, M., Frampton, G. M., Fenton, T., Feber, A., Palmer, G., Jay, A., Pillay, N., Forster, M., Cronin, M. T., Lipson, D., et al. (2013) · Genome Medicine · doi:10.1186/gm453 · Cited by 217
p63 in Epithelial Survival, Germ Cell Surveillance, and Neoplasia
Crum, C. P., & McKeon, F. D. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102117 · Cited by 215
Alcohol-Related Diseases of the Esophagus and Stomach
Franke, A., Teyssen, S., & Singer, M. V. (2005) · Digestive Diseases · doi:10.1159/000090167 · Cited by 214
Akt/Protein Kinase B Isoforms Are Differentially Regulated by Epidermal Growth Factor Stimulation
Okano, J.-I., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K., & Nakagawa, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004112200 · Cited by 213
Self-citationMultifocal Epithelial Tumors and Field Cancerization from Loss of Mesenchymal CSL Signaling
Hu, B., Castillo, E., Harewood, L., Ostano, P., Reymond, A., Dummer, R., Raffoul, W., Hoetzenecker, W., Hofbauer, G. F. L., & Dotto, G. P. (2012) · Cell · doi:10.1016/j.cell.2012.03.048 · Cited by 213
Self-citationTalora, C., Sgroi, D. C., Crum, C. P., & Dotto, G. P. (2002) · Genes & Development · doi:10.1101/gad.988902 · Cited by 206
Self-citationMartin, D., Abba, M. C., Molinolo, A. A., Vitale-Cross, L., Wang, Z., Zaida, M., Delic, N. C., Samuels, Y., Lyons, J. G., & Gutkind, J. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2417 · Cited by 204
Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
Kim, Y., Hammerman, P. S., Kim, J., Yoon, J.-A., Lee, Y., Sun, J.-M., Wilkerson, M. D., Pedamallu, C. S., Cibulskis, K., Yoo, Y. K., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.8556 · Cited by 202
Activation of the NOTCH Pathway in Head and Neck Cancer
Sun, W., Gaykalova, D. A., Ochs, M. F., Mambo, E., Arnaoutakis, D., Liu, Y., Loyo, M., Agrawal, N., Howard, J., Li, R., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1259 · Cited by 200
Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
Hedberg, M. L., Goh, G., Chiosea, S. I., Bauman, J. E., Freilino, M. L., Zeng, Y., Wang, L., Diergaarde, B. B., Gooding, W. E., Lui, V. W. Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82066 · Cited by 200
Regulation of Notch1 Gene Expression by p53 in Epithelial Cells
Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S.-I., Fujita, M., & Kiyono, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02119-06 · Cited by 199
Nrf2-A regulator of keratinocyte redox signaling
Schäfer, M., & Werner, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.018 · Cited by 192
Crosstalk of Notch with p53 and p63 in cancer growth control
Dotto, G. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2675 · Cited by 188
Self-citationKolev, V., Mandinova, A., Guinea-Viniegra, J., Hu, B., Lefort, K., Lambertini, C., Neel, V., Dummer, R., Wagner, E. F., & Dotto, G. P. (2008) · Nature Cell Biology · doi:10.1038/ncb1750 · Cited by 186
Self-citationSOX2 and p63 colocalize at genetic loci in squamous cell carcinomas
Watanabe, H., Ma, Q., Peng, S., Adelmant, G., Swain, D., Song, W., Fox, C., Francis, J. M., Pedamallu, C. S., DeLuca, D. S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71545 · Cited by 184
Self-citationMechanisms of cell transformation by papillomavirus E5 proteins
DiMaio, D., & Mattoon, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204915 · Cited by 183
Logié, A., Dunois-Lardé, C., Rosty, C., Levrel, O., Blanche, M., Ribeiro, A., Gasc, J.-M., Jorcano, J., Werner, S., Sastre-Garau, X., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi127 · Cited by 181
New roles for integrins in squamous-cell carcinoma
Janes, S. M., & Watt, F. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1817 · Cited by 178
Multifocal epithelial tumors and field cancerization: stroma as a primary determinant
Dotto, G. P. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72589 · Cited by 175
Self-citationAcetaldehyde and the genome: Beyond nuclear DNA adducts and carcinogenesis
Brooks, P. J., & Zakhari, S. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21824 · Cited by 170
Squamous Dysplasia—The Precursor Lesion for Esophageal Squamous Cell Carcinoma
Taylor, P. R., Abnet, C. C., & Dawsey, S. M. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1347 · Cited by 168
Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
Liao, R. G., Jung, J., Tchaicha, J., Wilkerson, M. D., Sivachenko, A., Beauchamp, E. M., Liu, Q., Pugh, T. J., Pedamallu, C. S., Hayes, D. N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3950 · Cited by 167
Cellular and sub-cellular responses to UVA in relation to carcinogenesis
Ridley, A. J., Whiteside, J. R., McMillan, T. J., & Allinson, S. L. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902740150 · Cited by 166
Karakasheva, T. A., Waldron, T. J., Eruslanov, E., Kim, S.-B., Lee, J.-S., O'Brien, S., Hicks, P. D., Basu, D., Singhal, S., Malavasi, F., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3639 · Cited by 166
Self-citationDumortier, A., Durham, A.-D., Di Piazza, M., Vauclair, S., Koch, U., Ferrand, G., Ferrero, I., Demehri, S., Song, L. L., Farr, A. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009258 · Cited by 164
FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer
Wang, R., Wang, L., Li, Y., Hu, H., Shen, L., Shen, X., Pan, Y., Ye, T., Zhang, Y., Luo, X., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0284 · Cited by 159
Goudie, D. R., D’Alessandro, M., Merriman, B., Lee, H., Szeverényi, I., Avery, S., O’Connor, B. D., Nelson, S. F., Coats, S. E., Stewart, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.780 · Cited by 157
Cancer epigenetics drug discovery and development: the challenge of hitting the mark
Campbell, R. M., & Tummino, P. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71605 · Cited by 157
Behrens, C., Solis, L. M., Lin, H. Y., Yuan, P., Tang, X., Kadara, H. N., Riquelme, E. M., Galindo, H., Moran, C. A., Kalhor, N., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3946 · Cited by 155
Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma
Modi, B. G., Neustadter, J. H., Binda, E., Lewis, J. M., Filler, R. B., Roberts, S. J., Kwong, B. Y., Reddy, S., Overton, J. D., Galan, A., et al. (2012) · Science · doi:10.1126/science.1211600 · Cited by 151
Novel mechanisms of EBV-induced oncogenesis
Raab‐Traub, N. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.07.001 · Cited by 149
Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma
Lee, C. S., Bhaduri, A., Mah, A., Johnson, W. L., Ungewickell, A., Aros, C. J., Nguyen, C. B., Rios, E. J., Siprashvili, Z., Straight, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3091 · Cited by 143
Lefort, K., & Dotto, G. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.017 · Cited by 136
Self-citationSleeping Giants: Emerging Roles for the Fat Cadherins in Health and Disease
Sadeqzadeh, E., de Bock, C. E., & Thorne, R. F. (2013) · Medicinal Research Reviews · doi:10.1002/med.21286 · Cited by 135
Ohashi, S., Natsuizaka, M., Yashiro–Ohtani, Y., Kalman, R. A., Nakagawa, M., Wu, L., Klein–Szanto, A. J., Herlyn, M., Diehl, J. A., Katz, J. P., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.040 · Cited by 135
Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity
Saburi, S., Hester, I., Goodrich, L. V., & McNeill, H. (2012) · Development · doi:10.1242/dev.077461 · Cited by 131
Arnault, J. P., Mateus, C., Escudier, B. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1344 · Cited by 123
Epstein-Barr virus latency: current and future perspectives
Kempkes, B., & Robertson, E. S. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.09.007 · Cited by 121
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma
Ramsey, M. R., Wilson, C., Ory, B., Rothenberg, S. M., Faquin, W. C., Mills, A. A., & Ellisen, L. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68899 · Cited by 115
Epstein–Barr virus and carcinogenesis: beyond Burkitt's lymphoma
Shah, K. S., & Young, L. S. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03033.x · Cited by 115
Solid Tumor Differentiation Therapy - Is It Possible?
Cruz, F. S. D., & Matushansky, I. (2012) · Oncotarget · doi:10.18632/oncotarget.512 · Cited by 114
Identification of altered cis-regulatory elements in human disease
Mathelier, A., Shi, W., & Wasserman, W. W. (2015) · Trends in Genetics · doi:10.1016/j.tig.2014.12.003 · Cited by 108
Natural history of bronchial preinvasive lesions
Ishizumi, T., McWilliams, A. M., MacAulay, C. E., Gazdar, A. F., & Lam, S. C. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9214-7 · Cited by 105
Aggressive squamous cell carcinomas in organ transplant recipients.
Euvrard, S., Kanitakis, J., Pouteil‐Noble, C., Disant, F., Dureau, G., de Villaine, J. F., Claudy, A., & Thivolet, J. (1995) · PubMed · Cited by 100
Wischermann, K., Popp, S., Moshir, S., Scharfetter-Kochanek, K., Wlaschek, M., de Gruijl, F., Hartschuh, W., Greinert, R., Volkmer, B., Faust, A., et al. (2008) · Oncogene · doi:10.1038/onc.2008.70 · Cited by 99
EZH2 as a potential target in cancer therapy
McCabe, M. T., & Creasy, C. L. (2014) · Epigenomics · doi:10.2217/epi.14.23 · Cited by 93
Ferone, G., Thomason, H. A., Antonini, D., Rosa, L. D., Hu, B., Gemei, M., Zhou, H., Ambrosio, R., Rice, D. P. C., Acampora, D., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100199 · Cited by 85
The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2Preprint
Xu, X., Huang, L., Futtner, C. R., Schwab, B., Rampersad, R. R., Lu, Y., Sporn, T. A., Hogan, B. L. M., & Onaitis, M. W. (2014) · Genes & Development · doi:10.1101/gad.243717.114 · Cited by 85
Mandinova, A., Lefort, K., di Vignano, A. T., Stonely, W., Ostano, P., Chiorino, G., Iwaki, H., Nakanishi, J., & Dotto, G. P. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.45 · Cited by 83
Self-citationMyeloid derived suppressor cells: Targets for therapy
Waldron, T. J., Quatromoni, J. G., Karakasheva, T. A., Singhal, S. K., & Rustgi, A. K. (2013) · OncoImmunology · doi:10.4161/onci.24117 · Cited by 81
Self-citationSchwaederle, M. C., Elkin, S. K., Tomson, B. N., Carter, J. L., & Kurzrock, R. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1053669 · Cited by 80
Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
Burtness, B. A., Bauman, J. E., & Galloway, T. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70085-8 · Cited by 80
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00339-7 · Cited by 79
Yang, H., Schramek, D., Adam, R. C., Keyes, B. E., Wang, P., Zheng, D., & Fuchs, E. V. (2015) · eLife · doi:10.7554/elife.10870 · Cited by 77
Toschi, L., Finocchiaro, G., Nguyen, T. T., Skokan, M. C., Giordano, L., Gianoncelli, L., Perrino, M., Siracusano, L., Tommaso, L. D., Infante, M. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095303 · Cited by 75
Talora, C., Cialfi, S., Segatto, O., Morrone, S., Choi, J. K., Frati, L., Dotto, G. P., Gulino, A., & Screpanti, I. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.015 · Cited by 74
Self-citationExpression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma
Schröck, A., Bode, M., Göke, F., Bareiss, P. M., Schairer, R., Wang, H., Weichert, W., Franzen, A., Kirsten, R., Bremen, T. V., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu094 · Cited by 74
Kagawa, S., Natsuizaka, M., Whelan, K. A., Facompre, N. D., Naganuma, S., Ohashi, S., Kinugasa, H., Egloff, A. M., Basu, D., Gimotty, P. A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.169 · Cited by 73
Self-citationNaeem, A. S., Zhu, Y., Di, W., Marmiroli, S., & O’Shaughnessy, R. F. L. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.62 · Cited by 70
He, L., Torres‐Lockhart, K., Forster, N., Ramakrishnan, S., Greninger, P., Garnett, M. J., McDermott, U., Rothenberg, S. M., Benes, C. H., & Ellisen, L. W. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0417 · Cited by 68
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis
Matin, R., Chikh, A., Chong, S. L. P., Mesher, D., Graf, M., Sanzà, P., Senatore, V., Scatolini, M., Moretti, F., Leigh, I. M., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121439 · Cited by 66
Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer
Brooks, Y., Ostano, P., Jo, S. H., Dai, J., Getsios, S., Dziunycz, P., Hofbauer, G. F. L., Cerveny, K. L., Chiorino, G., Lefort, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72718 · Cited by 63
Self-citationOral epithelial stem cells—Implications in normal development and cancer metastasis
Papagerakis, S. M., Pannone, G., Zheng, L. X., About, I., Taqi, N., Nguyen, N. P. T., Matossian, M. D., McAlpin, B. R., Santoro, A., McHugh, J. B., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.04.021 · Cited by 62
Survival of skin cancer stem cells requires the Ezh2 polycomb group protein
Adhikary, G., Grun, D., Balasubramanian, S., Kerr, C. L., Huang, J. M., & Eckert, R. L. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv064 · Cited by 61
OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action
Schroeder, M. P., Rubio-Pérez, C., Tamborero, D., González-Pérez, A., & López-Bigas, N. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu467 · Cited by 59
Targeted Therapy for Squamous Cell Lung Cancer
Liao, R. G., Watanabe, H., Meyerson, M. M., & Hammerman, P. S. (2012) · Lung Cancer Management · doi:10.2217/lmt.12.40 · Cited by 57
Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway
Campelo, M. R. G., Curbera, G. A., Gallego, G. A., Pulido, E. G., & Aparicio, L. M. A. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0622-0 · Cited by 55
Gross, N. D., Bauman, J. E., Gooding, W. E., Denq, W., Thomas, S. M., Wang, L., Chiosea, S. I., Hood, B. L., Flint, M. S., Sun, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3360 · Cited by 54
The Oncogene ATF3 Is Potentiated by Cyclosporine A and Ultraviolet Light A
Dziunycz, P., Lefort, K., Wu, X., Freiberger, S. N., Neu, J., Djerbi, N., Iotzova-Weiss, G., French, L. E., Dotto, G. P., & Hofbauer, G. F. L. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.77 · Cited by 53
Self-citationTargeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer
Botelho, M. C., Machado, J. C., Brindley, P. J., & da Costa, J. M. C. (2011) · Virulence · doi:10.4161/viru.2.4.16734 · Cited by 51
Yang, Y., Nakagawa, H., Tétreault, M.-P., Billig, J., Victor, N., Goyal, A., Sepulveda, A. R., & Katz, J. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1702 · Cited by 49
Coactivator MED1 Ablation in Keratinocytes Results in Hair-Cycling Defects and Epidermal Alterations
Oda, Y., Hu, L., Bul, V., Elalieh, H. Z., Reddy, J. K., & Bikle, D. D. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.430 · Cited by 48
Iida, M., Brand, T. M., Campbell, D. A., Starr, M. M., Luthar, N., Traynor, A. M., & Wheeler, D. L. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24342 · Cited by 48
Stem-Like Cells and Therapy Resistance in Squamous Cell Carcinomas
Facompre, N. D., Nakagawa, H., Herlyn, M., & Basu, D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00008-7 · Cited by 44
Genetic profiles of cervical tumors by high‐throughput sequencing for personalized medical care
Müller, E., Brault, B., Holmes, A. M., Legros, A., Jeannot, E., Campitelli, M., Rousselin, A., Goardon, N., Frébourg, T., Krieger, S., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.492 · Cited by 42
Escuin-Ordinas, H., Atefi, M. S., Fu, Y., Cass, A. A., Ng, C., Huang, R., Yashar, S., Comin-Anduix, B., Avramis, E. V., Cochran, A. J., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.005 · Cited by 42
Immune responses to S chistosoma haematobium infection
Odegaard, J. I., & Hsieh, M. H. (2014) · Parasite Immunology · doi:10.1111/pim.12084 · Cited by 39
Notch Signaling in CD66+ Cells Drives the Progression of Human Cervical Cancers
Bajaj, J., Maliekal, T. T., Vivien, É., Pattabiraman, C., Srivastava, S., Krishnamurthy, H., Giri, V. G., Subramanyam, D., & Krishna, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0543 · Cited by 38
Alterations in AP‐1 and AP‐1 Regulatory Genes during HPV‐Induced Carcinogenesis
de Wilde, J., Arce, J. D.-C., Snijders, P. J. F., Meijer, C. J. L. M., Rösl, F., & Steenbergen, R. D. M. (2008) · Analytical Cellular Pathology · doi:10.1155/2008/279656 · Cited by 38
Crosstalk among p53 family members in cutaneous carcinoma
Missero, C., & Antonini, D. (2014) · Experimental Dermatology · doi:10.1111/exd.12320 · Cited by 37
Squamous cell carcinoma and precursor lesions: clinical pathology
Woolgar, J. A., & Triantafyllou, A. G. (2011) · Periodontology 2000 · doi:10.1111/j.1600-0757.2011.00389.x · Cited by 37
Dotto, G. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3750 · Cited by 33
Self-citationPirker, R. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000162 · Cited by 29
EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
Robinson, K. W., & Sandler, A. B. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0323-7 · Cited by 26
p63, Sharp1, and HIFs: Master Regulators of Metastasis in Triple-Negative Breast Cancer
Piccolo, S., Enzo, E., & Montagner, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0962 · Cited by 24
Saoncella, S., Tassone, B., Deklic, E., Avolio, F., Jon, C., Tornillo, G., Luca, E. D., Iorio, E. D., Piva, R., Cabodi, S., et al. (2013) · Stem Cells · doi:10.1002/stem.1565 · Cited by 23
Cited by
Yuan, S., Norgard, R. J., & Stanger, B. Z. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0015 · Cited by 455
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.009 · Cited by 434
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
Pastushenko, I., Mauri, F., Song, Y., de Cock, F., Meeusen, B., Swedlund, B., Impens, F., Van Haver, D., Opitz, M., Thery, M., et al. (2021) · Nature · doi:10.1038/s41586-020-03046-1 · Cited by 429
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Testa, U., Castelli, G., & Pelosi, E. (2018) · Cancers · doi:10.3390/cancers10080248 · Cited by 403
Metaplasia: tissue injury adaptation and a precursor to the dysplasia–cancer sequence
Giroux, V., & Rustgi, A. K. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.68 · Cited by 354
Self-citation
Metadata
- Authors
- Dotto, G. P., & Rustgi, A. K.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 29
- Issue
- 5
- Pages
- 622-637
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2346530374
- Cited by
- 319
- References
- 173
- FWCI
- 21.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.